Ownership Change to Note: Perkinelmer Inc (NYSE:PKI) Sentiment Worsened, Despite Downtrend

November 29, 2016 - By Clifton Ray   ·   0 Comments

Ownership Change to Note: Perkinelmer Inc (NYSE:PKI) Sentiment  Worsened,  Despite Downtrend

Sentiment for Perkinelmer Inc (NYSE:PKI)

Perkinelmer Inc (NYSE:PKI) institutional sentiment decreased to 0.88 in 2016 Q2. Its down -0.54, from 1.42 in 2016Q1. The ratio dived, as 159 funds opened new or increased holdings, while 112 decreased and sold positions in Perkinelmer Inc. The funds in our partner’s database now have: 97.59 million shares, down from 97.85 million shares in 2016Q1. Also, the number of funds holding Perkinelmer Inc in their top 10 holdings increased from 5 to 7 for an increase of 2. Sold All: 23 Reduced: 89 Increased: 111 New Position: 48.

PerkinElmer, Inc. is a provider of products, services and solutions to the diagnostics, research, environmental and laboratory markets. The company has a market cap of $5.57 billion. The Company’s operating divisions include Human Health, Environmental Health and Corporate. It has a 24.3 P/E ratio. The Human Health segment concentrates on developing diagnostics, tools and applications to help detect diseases earlier.

About 191,759 shares traded hands. PerkinElmer, Inc. (NYSE:PKI) has declined 0.04% since April 26, 2016 and is downtrending. It has underperformed by 5.30% the S&P500.

Analysts await PerkinElmer, Inc. (NYSE:PKI) to report earnings on February, 2. They expect $0.87 EPS, up 1.16% or $0.01 from last year’s $0.86 per share. PKI’s profit will be $94.19 million for 14.78 P/E if the $0.87 EPS becomes a reality. After $0.68 actual EPS reported by PerkinElmer, Inc. for the previous quarter, Wall Street now forecasts 27.94% EPS growth.

According to Zacks Investment Research, “PerkinElmer, Inc. is a global technology company which provides products and systems to the telecom, medical, pharmaceutical, chemical, semiconductor and photographic markets. The Company has operations in over 100 countries, and is a component of the S&P 500 Index. The Company’s continuing operations are classified into four operating segments: Life Sciences, Optoelectronics, Instruments, and Fluid Sciences.”

Edinburgh Partners Ltd holds 9.77% of its portfolio in PerkinElmer, Inc. for 1.23 million shares. Sector Gamma As owns 543,710 shares or 5.77% of their US portfolio. Moreover, Nine Chapters Capital Management Llc has 4.27% invested in the company for 3,900 shares. The New York-based Robecosam Usa Inc. has invested 3.23% in the stock. Impax Asset Management Ltd, a United Kingdom-based fund reported 1.14 million shares.#img1#

Insider Transactions: Since January 1, 0001, the stock had 0 buys, and 5 selling transactions for $6.93 million net activity.

PerkinElmer, Inc. (NYSE:PKI) Ratings Coverage

Ratings analysis reveals 27% of PerkinElmer Inc’s analysts are positive. Out of 11 Wall Street analysts rating PerkinElmer Inc, 3 give it “Buy”, 1 “Sell” rating, while 7 recommend “Hold”. The lowest target is $40 while the high is $62. The stock’s average target of $53.30 is 3.60% above today’s ($51.45) share price. PKI was included in 22 notes of analysts from August 3, 2015. UBS maintained PerkinElmer, Inc. (NYSE:PKI) on Thursday, September 22 with “Buy” rating. As per Wednesday, August 26, the company rating was initiated by Cantor Fitzgerald. On Thursday, December 3 the stock rating was downgraded by Wedbush to “Neutral”. BTIG Research reinitiated the shares of PKI in a report on Friday, July 22 with “Neutral” rating. The rating was initiated by Deutsche Bank on Thursday, January 7 with “Hold”. On Thursday, August 27 the stock rating was maintained by Maxim Group with “Buy”. The firm has “Neutral” rating by Bank of America given on Tuesday, April 5. The rating was downgraded by Goldman Sachs on Tuesday, December 8 to “Sell”. The stock of PerkinElmer, Inc. (NYSE:PKI) earned “Buy” rating by Mizuho on Friday, May 6. Stifel Nicolaus maintained PerkinElmer, Inc. (NYSE:PKI) rating on Friday, February 5. Stifel Nicolaus has “Buy” rating and $51 price target.

PKI Company Profile

PerkinElmer, Inc., incorporated on November 13, 1947, is a well-known provider of products, services and solutions to the diagnostics, research, environmental, industrial and laboratory services markets. The Company’s operating divisions include Human Health, Environmental Health and Corporate. The Firm markets its services and products in over 150 countries.

Receive News & Ratings Via Email - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings with our FREE daily email newsletter.

By Clifton Ray


Readers Comments (0)





Free Email Newsletter

Enter your email address below to get the latest news and analysts' ratings for your stocks with our FREE daily email newsletter:


Recent Market News

>